Connecting vitamin D, the microbiome and anticancer immunity
Nature Reviews Immunology, Published online: 14 May 2024; doi:10.1038/s41577-024-01044-2Connecting vitamin D, the microbiome and anticancer immunity
Nature Reviews Immunology, Published online: 14 May 2024; doi:10.1038/s41577-024-01044-2Connecting vitamin D, the microbiome and anticancer immunity
Nature Reviews Immunology, Published online: 14 May 2024; doi:10.1038/s41577-024-01046-0Time of day determines cancer immunotherapy response
Nature Reviews Immunology, Published online: 14 May 2024; doi:10.1038/s41577-024-01045-1How the brain regulates inflammation
Nature Reviews Immunology, Published online: 08 May 2024; doi:10.1038/s41577-024-01042-4Commensal bacteria induce liver macrophages that protect the tissue against inflammation.
Nature Reviews Immunology, Published online: 07 May 2024; doi:10.1038/s41577-024-01025-5This Review from Comerford and McColl discusses recent advances that have been made in understanding the biology of the atypical chemokine receptor…
Nature Reviews Immunology, Published online: 02 May 2024; doi:10.1038/s41577-024-01029-1An optimal immune response to influenza virus strikes a balance between protective antiviral immune mechanisms and detrimental immunopathology. Her…
Nature Reviews Immunology, Published online: 02 May 2024; doi:10.1038/s41577-024-01030-8Compared with many other vaccines, current vaccines against influenza provide only limited protection. Here, the authors describe the challenges an…
Nature Reviews Immunology, Published online: 29 April 2024; doi:10.1038/s41577-024-01027-3Here, Rongbin Zhou and colleagues review the different types of damage-associated molecular pattern (DAMP) that trigger sterile inflammation via …
Nature Reviews Immunology, Published online: 26 April 2024; doi:10.1038/s41577-024-01039-zWei et al. report a role for membrane perforation mediated by gasdermin D pores in disruption of the blood–brain barrier.
Nature Reviews Immunology, Published online: 26 April 2024; doi:10.1038/s41577-024-01038-0A preprint by Yi et al. shows a role for the FAS signalling pathway in controlling the persistence of CAR-modified lymphocytes.